Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,745 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prostate Cancer Screening and Diagnoses in the Transfeminine Population.
Stephens A, Morrison C, Lutchka J, Richard C, Hares K, Tinsley S, Sood A, Shannon B, Rogers C, Shill J, Shakir N, Abdollah F. Stephens A, et al. Among authors: richard c. Urology. 2024 Nov 21:S0090-4295(24)01083-5. doi: 10.1016/j.urology.2024.11.029. Online ahead of print. Urology. 2024. PMID: 39580118
Surgery versus radiation for clinically positive nodal prostate cancer in an other cause mortality risk weighted cohort.
Tinsley SA, Stephens A, Finati M, Chiarelli G, Cirulli GO, Morrison C, Richard C, Hares K, Lutchka J, Sood A, Buffi N, Lughezzani G, Bettocchi C, Salonia A, Briganti A, Montorsi F, Carrieri G, Rogers C, Abdollah F. Tinsley SA, et al. Among authors: richard c. Int Urol Nephrol. 2024 Nov 11. doi: 10.1007/s11255-024-04253-9. Online ahead of print. Int Urol Nephrol. 2024. PMID: 39528898
Race has no impact on prostate cancer-specific mortality, when comparing patients with similar risk of other-cause mortality: An analysis of a population-based cohort.
Tinsley SA, Finati M, Stephens A, Chiarelli G, Cirulli GO, Williams E, Morrison C, Richard C, Hares K, Sood A, Buffi N, Lughezzani G, Bettocchi C, Salonia A, Briganti A, Montorsi F, Carrieri G, Rogers C, Abdollah F. Tinsley SA, et al. Among authors: richard c. Cancer. 2024 Sep 15;130(18):3157-3169. doi: 10.1002/cncr.35386. Epub 2024 May 28. Cancer. 2024. PMID: 38804713
Prospective validation of ORACLE, a clonal expression biomarker associated with survival of patients with lung adenocarcinoma.
Biswas D, Liu YH, Herrero J, Wu Y, Moore DA, Karasaki T, Grigoriadis K, Lu WT, Veeriah S, Naceur-Lombardelli C, Magno N, Ward S, Frankell AM, Hill MS, Colliver E, de Carné Trécesson S, East P, Malhi A, Snell DM, O'Neill O, Leonce D, Mattsson J, Lindberg A, Micke P, Moldvay J, Megyesfalvi Z, Dome B, Fillinger J, Nicod J, Downward J, Szallasi Z; TRACERx Consortium; Hackshaw A, Jamal-Hanjani M, Kanu N, Birkbak NJ, Swanton C. Biswas D, et al. Nat Cancer. 2025 Jan 9. doi: 10.1038/s43018-024-00883-1. Online ahead of print. Nat Cancer. 2025. PMID: 39789179
Intelligent Hierarchical Targeting Near-Infrared Persistent Luminescence Nanosystem for Improved Nuclear Delivery and Simultaneous Visualization/Therapy of EBV-Associated Cancer.
Zhu Y, Wen Y, Xie Y, Chen G, Hu S, Wu Y, Jiang L, Viana B, Richard C, Wong KL, Jiao J, Wang J, Zou R. Zhu Y, et al. Among authors: richard c. ACS Appl Mater Interfaces. 2025 Jan 3. doi: 10.1021/acsami.4c20023. Online ahead of print. ACS Appl Mater Interfaces. 2025. PMID: 39752553
1,745 results